ବ୍ରେନ୍ ଟ୍ୟୁମର (ମେଡୁଲୋବ୍ଲାଷ୍ଟୋମା)
Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
କେଉଁଠିକୁ ଯିବେ
ଏହି trial ପାଇଁ ଭାରତରେ ୧ଟି hospital ରୋଗୀଙ୍କୁ ନେଉଛି।
ରେଜିଷ୍ଟ୍ରି ସାରାଂଶ (ଟେକ୍ନିକାଲ୍)
Radiation constitutes an integral component in the management of primary brain tumors in pediatric and young adults like medulloblastoma, ependymoma, low-grade glioma, pituitary tumors, etc. A decline in neurocognitive outcomes is a multifactorial effect occurring from the primary disease as well as associated with treatments, including radiation. Since many of these tumors are highly curable, it is crucial to reduce long-term side effects, including memory loss, to improve the quality of life in these patients, leading to better rehabilitation. Radiation-induced neurocognitive deterioration i…
Sponsor: Tata Memorial Centre
NCT06779487 on ClinicalTrials.gov
Last updated on the registry 11 Apr 2025 · read by us 20 Oct 2026